← Back to Search

Cool Ropivacaine Block for Local Anesthesia

Phase 1
Waitlist Available
Led By Daniel Wambold, MD
Research Sponsored by Daniel Wambold
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 35 minutes
Awards & highlights

Study Summary

This trial is testing whether cooling the injected painkiller ropivacaine before surgery will prolong its pain-relieving effects, and thus reduce the amount of opioids needed afterwards.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~35 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 35 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time to block of pain and thermosensory perception
Secondary outcome measures
Morphine equivalency units of adjunct pain medications

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Cool BlockExperimental Treatment1 Intervention
Ropivacaine administered at approximately 4C, via a TAP block.
Group II: Room Temp BlockActive Control1 Intervention
Ropivacaine administered at approximately 20-25C, via a TAP block.

Find a Location

Who is running the clinical trial?

Daniel WamboldLead Sponsor
Daniel Wambold, MDPrincipal InvestigatorUniversity of Kentucky

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~0 spots leftby Apr 2025